Discover 4,047 paid clinical trials in Bronx, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 4,047
Active & Responsive
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Location: New York NY, Valhalla NY, Morristown NJ,
Sponsor: Chris Goss
Sex: All
Age: 6+
Code: NCT05548283
Recruiting
Active & Responsive
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment
for
Alagille Syndrome
Location: New York NY, St Louis MO, Memphis TN, Kansas City MO,
Location: New York NY, New Haven CT, Philadelphia PA,
Sponsor: Mezzion Pharma Co. Ltd
Sex: All
Age: 12 - 18
Code: NCT05918211
Phase 3, Recruiting
Active & Responsive
A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering
for
Scoliosis Idiopathic
Location: New York NY, Philadelphia PA, Washington D.C. DC,
Sponsor: Pediatric Spine Foundation
Sex: All
Age: 0 - 18
Code: NCT04914507
Recruiting
Active & Responsive
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
for
Cancer, PDAC - Pancreatic Ductal Adenocarcinoma,
Location: New York NY, Boston MA, Fairfax VA, Durham NC,
Sponsor: Alterome Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06835569
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: New York NY, Brooklyn NY, Media PA, East Greenwich RI,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase 3, Recruiting
Active & Responsive
Effects of GH and Lirglutide on AgRP
for
Healthy, Growth Hormone Deficiency
Location: New York NY
Sponsor: Columbia University
Sex: All
Age: 18 - 45
Code: NCT05681299
Recruiting
Active & Responsive
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
for
Amyotrophic Lateral Sclerosis
Location: New York NY, Philadelphia PA, Boston MA, Baltimore MD,
Sponsor: Prilenia
Sex: All
Age: 18 - 70+
Code: NCT07322003
Phase 3, Recruiting
Active & Responsive
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
for
Alpha1-Antitrypsin Deficiency
Location: New York NY, Philadelphia PA, Hershey PA, Boston MA,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT05677971
Phase 3, Recruiting
Active & Responsive
The DREAM Study: A Multidimensional Sleep Health Intervention for Improving Cardiometabolic Health
for
Blood Pressure
Location: New York NY
Sponsor: Columbia University
Sex: All
Age: 30+
Code: NCT06285968
Recruiting
Active & Responsive
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Location: New York NY, Mineola NY, New Brunswick NJ, New Haven CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03816345
Phase 1, Recruiting
Active & Responsive
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
for
Plasma Cell Myeloma
Location: New York NY, Greenwich CT, Stamford CT, Fairfield CT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT05561387
Phase 3, Recruiting
Active & Responsive
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
for
PIK3CA Mutation, Solid Tumor, Adult,
Location: New York NY, New Brunswick NJ, New Haven CT, Boston MA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05216432
Phase 1, Recruiting
Active & Responsive
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
for
Spinal Muscular Atrophy (SMA)
Location: New York NY, Hartford CT, Boston MA, Hillsborough NC,
Sponsor: argenx
Sex: All
Age: 5 - 17
Code: NCT07287982
Phase 2, Recruiting
Active & Responsive
taVNS for Persistent Symptoms From Lyme Disease
for
Post-Treatment Lyme Disease
Location: New York NY
Sponsor: Columbia University
Sex: All
Age: 18 - 65
Code: NCT05776251
Recruiting
Active & Responsive
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder
for
Cannabis Withdrawal
Location: New York NY, Staten Island NY, New Haven CT, Marlton NJ,